PUGLISI, SORAYA
 Distribuzione geografica
Continente #
EU - Europa 74
NA - Nord America 27
AS - Asia 6
Totale 107
Nazione #
IT - Italia 32
US - Stati Uniti d'America 27
IE - Irlanda 24
FR - Francia 9
PL - Polonia 6
VN - Vietnam 4
GB - Regno Unito 2
JP - Giappone 1
RU - Federazione Russa 1
SG - Singapore 1
Totale 107
Città #
Dublin 24
Messina 23
Columbus 11
Warsaw 6
Ashburn 4
Dong Ket 4
Boardman 2
Council Bluffs 2
Paris 2
Chiyoda 1
Codogno 1
Manchester 1
Milpitas 1
Mountain View 1
Rome 1
San Diego 1
Totale 85
Nome #
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment, file de3e52b3-10f9-762d-e053-3705fe0a30e0 22
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma, file de3e52b1-4511-762d-e053-3705fe0a30e0 21
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients, file de3e52b3-77af-762d-e053-3705fe0a30e0 20
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy, file de3e52b1-eb49-762d-e053-3705fe0a30e0 18
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide, file de3e52b3-10fc-762d-e053-3705fe0a30e0 15
How to improve effectiveness of pegvisomant treatment in acromegalic patients, file de3e52b1-450f-762d-e053-3705fe0a30e0 3
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy, file de3e52b3-9850-762d-e053-3705fe0a30e0 3
How to improve effectiveness of pegvisomant treatment in acromegalic patients, file de3e52b3-a0cf-762d-e053-3705fe0a30e0 3
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma, file de3e52b3-766d-762d-e053-3705fe0a30e0 2
Totale 107
Categoria #
all - tutte 394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 1 0 0 0
2020/202134 3 0 0 2 0 14 0 0 2 8 0 5
2021/20225 0 0 0 0 2 0 0 1 1 0 1 0
2022/202336 1 1 0 0 1 1 1 2 24 0 4 1
2023/202431 0 1 1 4 0 0 8 2 2 0 13 0
Totale 107